102 CHEMBL615820 Binding affinity against 5-hydroxytryptamine 1A receptor (5-HT1A) by displacement of [3H]8-OH-DPAT from rat hippocampus membranes
281 CHEMBL616344 Binding affinity of a compound to rat brain 5-hydroxytryptamine 1A (serotonin) receptor assayed by radiolabeled [3H]-8-OH-DPAT ligand displacement
104 CHEMBL617210 In vitro binding affinity for serotonin 5-hydroxytryptamine (5-HT) 2 receptors
113 CHEMBL620004 Inhibition of 5-lipoxygenase on rat basophil leukemia cell line lysate (RBL-1 2H3 subline) by measuring 5-HETE production
108 CHEMBL618396 In vitro inhibitory activity against 5-lipoxygenase in rat basophilic leukemia cells(RBL-1)
111 CHEMBL858253 Logarithmic value of inhibitory concentration against 5-lipoxygenase in rat basophilic leukemia cells (RBL-1)
114 CHEMBL621004 Antitumor activity in vivo against the 6C3HED lymphosarcoma, dosed for 10 days at 300 mg/kg
120 CHEMBL618310 Unbound fraction (plasma)
120 CHEMBL624569 Observed volume of distribution
113 CHEMBL618471 Plasma drug AUC in rat (PO dose)
113 CHEMBL623289 Plasma drug Cmax in rat (PO dose)
104 CHEMBL632070 Oral bioavailability in rat
106 CHEMBL629261 Plasma drug Tmax in rat (PO dose)
103 CHEMBL633638 Solubility (buffer pH 7.4)
112 CHEMBL633649 Delta logD (logD6.5 - logD7.4)
101 CHEMBL635482 Partition coefficient (logP)
230 CHEMBL633737 Partition coefficient (logP)
119 CHEMBL636294 HPLC capacity factor (k')
134 CHEMBL633695 Component deacylation rate constant for interaction with human leukocyte elastase
158 CHEMBL633696 Component acylation rate constant for interaction with human leukocyte elastase
181 CHEMBL633895 Ionization constant (pKa)
101 CHEMBL641772 Plasma T1/2 in rat (IV dose)
115 CHEMBL634283 Partition coefficient (logD6.5)
120 CHEMBL636806 Partition coefficient (logP)
152 CHEMBL636394 Delta logD (logD6.5 - logD7.4)
153 CHEMBL646647 Partition coefficient (logD6.5)
102 CHEMBL640840 Ionization constant (pKa)
204 CHEMBL645153 Ionization constant (pKa)
185 CHEMBL633098 Oral bioavailability in human
154 CHEMBL644792 In vitro inhibitory activity against acyl coenzyme A:cholesterol acyltransferase (ACAT)
139 CHEMBL644793 In vitro inhibition of acyl coenzyme A:cholesterol acyltransferase
116 CHEMBL644794 In vitro inhibitory activity against acyl coenzyme A:cholesterol acyltransferase
167 CHEMBL641707 In vitro inhibitory activity against acyl coenzyme A:cholesterol acyltransferase 1 in microsomes of rat liver
133 CHEMBL648337 Inhibitory activity against angiotensin converting enzyme (ACE)
132 CHEMBL652259 In vitro antagonist activity against rat prostatic androgen receptor (AR)
102 CHEMBL650164 Binding affinity against Angiotensin II receptor, from rat adrenal gland
121 CHEMBL654200 Binding affinity against cytosolic androgen receptor from ventral prostate of rats using [3H]MIB competitive binding assay (relative to dihydro testosterone)
101 CHEMBL652869 In vitro inhibitory activity against angiotensin II rabbit aorta AT1 receptor using radioligand [125I]-Sar Ile-AII
101 CHEMBL651250 In vitro inhibitory activity against angiotensin II rat midbrain AT2 receptor using radioligand [125I]-Sar Ile-AII
103 CHEMBL649169 Antifungal activity against Aspergillus fumigatus Saito strain
189 CHEMBL648388 In vitro antifungal activity against Aspergillus fumigatus
116 CHEMBL647385 Minimum inhibitory concentration (MIC) against Aspergillus fumigatus
130 CHEMBL657821 Inhibitory activity against human carbonic anhydrase I (CA1)
103 CHEMBL649945 Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
138 CHEMBL652492 Concentration required to inhibit growth of CCRF-CEM cells in culture for 72 hr to 50% of control growth
102 CHEMBL653322 In vitro beta-2 duration was determined using electrically stimulated guinea-pig isolated trachea superfusion system
103 CHEMBL659114 Antifungal activity against Candida albicans C-A-24 strain
189 CHEMBL656628 In vitro antifungal activity against Candida albicans
189 CHEMBL658433 Minimum effective concentration for inhibition of pseudomycelium formation in Candida albicans
151 CHEMBL653167 Inhibition of human recombinant carbonic anhydrase I (CA1)
246 CHEMBL658042 Inhibitory activity against Human carbonic anhydrase II
130 CHEMBL657146 Inhibitory activity against human carbonic anhydrase II (CA2)
131 CHEMBL657153 Inhibitory activity against human recombinant carbonic anhydrase II (CA2)
155 CHEMBL657194 Inhibition of human recombinant carbonic anhydrase II (CA2)
247 CHEMBL658217 Inhibitory activity against bovine carbonic anhydrase IV
130 CHEMBL658749 Inhibitory activity against bovine carbonic anhydrase IV (CA4), isolated from bovine lung microsomes
130 CHEMBL657028 Inhibitory activity against bovine carbonic anhydrase IV (CA4), isolated from bovine lung microsomes
155 CHEMBL657032 Inhibition of bovine carbonic anhydrase IV (CA4) from bovine lung microsomes
117 CHEMBL662556 Minimum inhibitory concentration (MIC) against Candida albicans
246 CHEMBL662724 Inhibitory activity against Human carbonic anhydrase I
131 CHEMBL657828 Inhibitory activity against human recombinant carbonic anhydrase I (CA1)
151 CHEMBL660105 MHC class I HLA-A*0201 binding affinity assayed by based inhibition of binding of a radiolabeled standard peptide (FLPSDYFPSV)
118 CHEMBL656248 Inhibition of binding of [125I]-CCK-8 to the cholecystokinin type B receptor
137 CHEMBL662294 Mammalian cell cytotoxicity test in chinese hamster V79 cells (clonogenic cytotoxicity)
140 CHEMBL663407 Inhibition of Coagulation factor Xa
132 CHEMBL659628 Half-maximal inhibition of [125I]-CCK-8(+) binding to cholecystokinin receptor from guinea pig brain tissue
112 CHEMBL663474 Half-maximal inhibition of [125I]CCK-33 binding to cholecystokinin A receptor from rat pancreatic tissue
108 CHEMBL660813 Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
115 CHEMBL662400 Inhibition of binding of [125I]CCK-8 to cholecystokinin type A receptor in rat pancreatic tissue
113 CHEMBL664960 Binding affinity to recombinant human Corticotropin releasing factor receptor 1 (hCRF1) expressed in 293EBNA cells
103 CHEMBL666216 Antifungal activity against Cryptococcus neoformans Cr-1 strain
154 CHEMBL668904 Percentage of intracellular covalent DNA-topoisomerase II complexes formed
185 CHEMBL669614 Inhibitory activity against dihydrofolate reductase (DHFR) isolated from murine L5178Y tumor cells resistant and sensitive to methotrexate
107 CHEMBL666235 The concentration required to inhibit dihydrofolate reductase in rat liver
128 CHEMBL858231 Inhibition of dihydrofolate reductase from rat Walker 256 leukemia tumors
103 CHEMBL666238 Concentration required for inhibition of rat liver dihydrofolate reductase (DHFR)
120 CHEMBL670366 In vitro binding affinity towards dopamine receptor D2
104 CHEMBL670641 Antagonist activity towards human recombinant Endothelin B receptor expressed in chinese hamster ovary (CHO) cells determined using [125I]ET1 as radioligand
173 CHEMBL858400 Inhibition of human leukocyte elastase
102 CHEMBL676676 In vitro growth inhibition against Entamoeba histolytica
104 CHEMBL682357 Antagonist activity towards human recombinant Endothelin A receptor expressed in chinese hamster ovary (CHO) cells determined using [125I]ET1 as radioligand
111 CHEMBL679318 Minimum inhibitory concentration against Escherichia coli
144 CHEMBL683045 Binding affinity for human recombinant gamma-aminobutyric-acid (GABA) A receptor alpha-6-beta-3-gamma-2
146 CHEMBL678329 Binding affinity for human recombinant gamma-aminobutyric-acid (GABA) A receptor alpha-1-beta-3-gamma-2
136 CHEMBL681248 Binding affinity to human recombinant gamma-aminobutyric-acid (GABA) A receptor alpha-2-beta-3-gamma-2
101 CHEMBL678836 The compound was tested for the inhibition of fibrinogen receptor
146 CHEMBL682251 Binding affinity for human recombinant gamma-aminobutyric-acid (GABA) A receptor alpha-3-beta-3-gamma-2
157 CHEMBL681296 In vitro inhibition of farnesyltransferase farnesylation of the H-ras oncogene
149 CHEMBL681480 Binding affinity for human recombinant gamma-aminobutyric-acid (GABA) A receptor alpha-5-beta-3-gamma-2
131 CHEMBL682682 Antibacterial activity against five Gram-negative bacteria
131 CHEMBL682431 Antibacterial activity against five Gram-positive bacteria targeting topoisomerase II (DNA gyrase B GyrB)
131 CHEMBL687330 Half-maximal inhibition of [125I]gastrin binding to guinea pig gastric glands
130 CHEMBL686430 Percent inhibition of gastric proton-pump enzyme H+/K+ ATPase was determined at 50 uM
110 CHEMBL688289 Inhibition of K+ -stimulated gastric ATPase activity was measured using lyophilized gastric vesicles at pH 7
110 CHEMBL690110 In vitro antimicrobial activity against Haemophilus influenzae.
117 CHEMBL693364 Inhibition of HIV-1 replication in human T-cell by using XTT assay; Inactive
142 CHEMBL697213 Inhibition of HIV-1 replication in a proliferating human T-cell line assayed using an XTT assay.
171 CHEMBL698689 In vitro inhibition of histamine release from human basophils
203 CHEMBL698692 Inhibitory activity against histamine release from antigen-challenged, sensitized human basophils
119 CHEMBL698300 Binding affinity for imidazoline receptor I-2 in rabbit kidney homogenate (relative to [3H]-Idazoxan radioligand)
105 CHEMBL699705 Inhibition constant (Ki) for human intestinal peptide carrier
103 CHEMBL697889 Binding affinity was determined against ionotropic glutamate receptor AMPA in rat brain synaptic membranes using [3H]AMPA as radioligand
102 CHEMBL700364 Toxicity evaluated against human nasopharyngeal carcinoma KB cell line
263 CHEMBL702934 Tumor cell selectivity determined as maximal percent increase in life span (ILSmax) at LD10 dosage level in L1210 cells
776 CHEMBL703726 Drug concentration in mole/kg/day providing 50% extension of life in intraperitoneally implanted leukemia L1210 mice.
112 CHEMBL709406 lowest concentration at which glucose utilized was greater than or equal to 140% of control value tested in a glucose utilization L6 myocyte in vitro assay
177 CHEMBL708445 Effective concentration required for the inhibition of HIV-1 IIIB in MT-4 cells
132 CHEMBL715566 Negative logarithm of relative affinity (pRA) towards melatonin receptor (relative to N-acetyl-5-methoxytryptamine (aMT))
141 CHEMBL856174 Melatonin receptor type 1A binding affinity measured using 2-[125I]iodomelatonin on ovine pars tuberalis membrane homogenates.
103 CHEMBL723207 Maximally tolerated dose was measured after ip administration of compound, 24 hr after tumor implantation.
125 CHEMBL724601 Antimalarial effect against trophozoite-induced Plasmodium berghei in mice (Mus musculus) at 160 mg/kg subcutaneous dose
101 CHEMBL718071 Antimalarial effect against trophozoite-induced Plasmodium berghei in mice (Mus musculus) after 20 mg/kg subcutaneous dose
166 CHEMBL719448 Antimalarial effect against trophozoite-induced Plasmodium berghei in mice (Mus musculus) after 40 mg/kg subcutaneous dose
121 CHEMBL726033 Acute toxicity determined after intravenal administration in mice
105 CHEMBL738589 Lethal dose in mice determined by Litchfield and Wilcoxon methods after peroral administration.
118 CHEMBL742791 Antimalarial activity in Plasmodium berghei infected mice (Mus musculus) after subcutaneous 160 mg/kg dose
107 CHEMBL742793 Antimalarial activity in Plasmodium berghei infected mice (Mus musculus) after subcutaneous 320 mg/kg dose
134 CHEMBL742795 Antimalarial activity in Plasmodium berghei infected mice (Mus musculus) after subcutaneous 640 mg/kg dose
128 CHEMBL741257 BBB penetration classification
102 CHEMBL740973 Concentration required to inhibit electrically induced contractions in isolated mouse vas deferens preparation in vitro
132 CHEMBL744488 Antimalarial activity in Plasmodium berghei infected mice (Mus musculus) after 160 mg/kg subcutaneous dose
164 CHEMBL746074 Antimalarial activity in Plasmodium berghei infected mice (Mus musculus) after 40 mg/kg subcutaneous dose
101 CHEMBL745188 Antimalarial activity in Plasmodium berghei infected mice (Mus musculus) after 80 mg/kg subcutaneous dose
103 CHEMBL752848 100% inhibition of growth of clofazimine resistant Mycobacterium smegmatis 607 strain in vitro
104 CHEMBL752850 Concentration for 100% inhibition of growth of dapsone sensitive Mycobacterium smegmatis 607 strain in vitro
103 CHEMBL752851 100% inhibition of growth of rifampicin resistant Mycobacterium smegmatis 607 strain in vitro
118 CHEMBL747348 Minimum inhibitory concentration (MIC) against Mycobacterium tuberculosis H 37 Ra
163 CHEMBL753724 Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
102 CHEMBL769481 In vitro growth inhibition against Plasmodium falciparum
211 CHEMBL759923 Antimalarial activity against chloroquine-resistant, mefloquine-sensitive Plasmodium falciparum W2
107 CHEMBL765007 Binding affinity against HIV-1 protease
118 CHEMBL763303 Inhibition of HIV-1 protease
139 CHEMBL763159 Inhibition of human Prostaglandin G/H synthase 2 at 0.1 ug/mL expressed as mean percent inhibition of control PGE-2 production
139 CHEMBL763160 Inhibition of human Prostaglandin G/H synthase 2 at 1 ug/mL expressed as mean percent inhibition of control PGE-2 production
138 CHEMBL763161 Inhibition of human Prostaglandin G/H synthase 2 at 10 ug/mL expressed as mean percent inhibition of control PGE-2 production
305 CHEMBL763870 Inhibition of human Prostaglandin G/H synthase 2
114 CHEMBL858334 Inhibitory activity against prostaglandin G/H synthase 2 (COX-2)
109 CHEMBL772766 In vitro inhibitory concentration required to block recombinant human prostaglandin G/H synthase 1 (COX-1)
139 CHEMBL765124 Inhibition of human Prostaglandin G/H synthase 1 at 0.1 ug/mL expressed as mean percent inhibition of control PGE-2 production
139 CHEMBL765125 Inhibition of human Prostaglandin G/H synthase 1 at 1 ug/mL expressed as mean percent inhibition of control PGE-2 production
139 CHEMBL765126 Inhibition of human Prostaglandin G/H synthase 1 at 10 ug/mL expressed as mean percent inhibition of control PGE-2 production
177 CHEMBL859312 Inhibitory activity was determined against HIV type 1 protease
109 CHEMBL763093 In vitro inhibitory concentration required to block human recombinant prostaglandin G/H synthase 2 (COX-2)
158 CHEMBL761820 Inhibition of purified recombinant HIV-1 protease at 0.5 nm using a fluorogenic substrate
114 CHEMBL768926 In vitro inhibitory activity against human recombinant protein tyrosine phosphatase 1b (PTP1B)
113 CHEMBL774080 Inhibition of 5-N-(ethyl isopropyl)-amiloride[EIPA]-sensitive Na+ uptake into acidified rabbit erythrocytes.
142 CHEMBL779006 Acute in vivo activity measured by total plasma cholesterol concentration levels (TC) at 30 mg/kg dose
113 CHEMBL777980 In vivo sterol lowering activity when dosed as 0.01 % of the diet
116 CHEMBL778126 In vivo sterol lowering activity when dosed as 0.03 % of the diet
162 CHEMBL778138 In vivo sterol lowering activity at dose of 0.10 % of the diet
110 CHEMBL778149 In vivo triglyceride lowering activity when dosed as 0.01 % of the diet
112 CHEMBL777443 In vivo triglyceride lowering activity when dosed at 0.03 % of the diet
123 CHEMBL778215 In vivo triglyceride lowering activity dosed at 0.10 % of the diet
158 CHEMBL778821 In vivo triglyceride lowering activity dosed at 0.10 % of the diet.
136 CHEMBL781365 Effective dose determined against rat adjuvant arthritis after peroral administration
107 CHEMBL783014 Hypotensive index (HI) measured as the area under the time-hypotensive response curve for 6-h period at 30 mg/kg, po
143 CHEMBL787110 Minimal effective dose in an rat anti-immobility effect using behavioral despair test
164 CHEMBL819742 Inhibitory activity against beta-lactamase renal dipeptidase
104 CHEMBL793222 Incidence of arrhythmias in rats after a intravenal administration at 4 mg/kg, expressed as no. of positive cases out of no. of tested cases (10)
103 CHEMBL789170 Reduction in paw swelling at 100 mg/kg po dose in rat using adjuvant arthritis test.
185 CHEMBL844273 Binding energy by using the equation deltaG obsd = -RT ln KD
122 CHEMBL802759 In vitro inhibitory activity against human immunodeficiency virus type 1 (HIV-1) reverse transcriptase (RT)
121 CHEMBL798029 In vitro inhibitory activity against human immunodeficiency virus type 1 (HIV-1) reverse transcriptase (RT) at a concentration of 10 ug/mL.
262 CHEMBL803376 Inhibitory activity against human immunodeficiency virus type 1 reverse transcriptase (HIV-1 RT)
207 CHEMBL799656 Mutagenic activity in an Ames test on Salmonella Typhimurium TA98; Activity is log of revertants/nmol
116 CHEMBL804051 Minimum inhibitory concentration against staphylococcus aureus ATCC 6538
122 CHEMBL807240 In vitro binding affinity for the mouse sigma opioid receptor
115 CHEMBL806152 Inhibition of binding of Batrachotoxinin [3H]BTX-B to high affinity sites on voltage dependent sodium channels in a vesicular preparation from guinea pig cerebral cortex
163 CHEMBL806153 Inhibition of binding of Batrachotoxinin [3H]BTX-B to high affinity sites on voltage dependent sodium channels in a vesicular preparation from guinea pig cerebral cortex at 10 uM
110 CHEMBL812966 In vitro antimicrobial activity against Streptococcus epidermidis EPI1
110 CHEMBL807231 In vitro antimicrobial activity against Staphylococcus aureus X1
135 CHEMBL814228 Ratio of IC50 to that of 10x compound against Steroid 5-alpha-reductase
109 CHEMBL812245 In vitro antimicrobial activity against Streptococcus pneumoniae
109 CHEMBL813256 In vitro antimicrobial activity against Streptococcus faecium X66
110 CHEMBL813820 In vitro antimicrobial activity against Staphylococcus pyogenes C203
102 CHEMBL808362 Effective dose after subcutaneous administration to TPTX rats for 50% reduction of hypercalcemia
776 CHEMBL813896 Compound concentration in mole/kg/day lethal to 10% of mice
189 CHEMBL812601 In vitro antifungal activity against Trichophyton asteroides
110 CHEMBL812602 Minimum inhibitory concentration against Trichophyton asteroides
103 CHEMBL812603 Antifungal activity towards Trichophyton interdigitale
117 CHEMBL879102 Inhibitory activity against human thrombin (using Chromozym TH as the substrate)
102 CHEMBL809380 Compound tested for ability to form a cellular covalent topoisomerase II-DNA complex.
177 CHEMBL814783 Cytotoxicity was determined against uninfected MT-4 cells
111 CHEMBL814407 Inhibitory activity for thromboxane synthetase determined by TXB2 levels in platelets from spontaneously hypertensive rats.
109 CHEMBL816529 Bovine thrombin concentration at which clotting time was prolonged 2x over the control.
163 CHEMBL812860 Inhibition of radioligand [3H]AVP binding to the vasopressin V1 receptor in rat liver tissue
163 CHEMBL817099 Inhibition of radioligand [3H]-AVP binding to the vasopressin V2 receptor in rat kidney tissue
103 CHEMBL815146 Antifungal activity towards Trichophyton mentagrophytes 530324 strain
103 CHEMBL817769 Inhibition of tubulin polymerization interacting at the colchicine binding site.
116 CHEMBL815469 Inhibitory activity against human trypsin (using Chromozym TH as the substrate)
101 CHEMBL822459 In vivo for cholesterol absorption inhibitory activity using 7-day cholesterol-fed hamster model (expressed as percent change in cholesteryl esters at 50 mg/kg/day)
101 CHEMBL822460 In vivo cholesterol absorption inhibitory activity using 7-day cholesterol-fed hamster model (expressed as percent change in serum cholesterol at 50 mg/kg/day)
103 CHEMBL823404 Inhibition of PAF induced platelet aggregation in rabbit
113 CHEMBL848104 Ratio of peak plasma concentration (Cmax) of the compound/EC50 of the compound
115 CHEMBL852790 Ratio of effect of compound on affinity of hemoglobin for oxygen to that of control
119 CHEMBL850566 Selectivity ratio between CCK-B and CCK-A receptor
106 CHEMBL848034 Bitter threshold value
167 CHEMBL847678 Sweet potency as logarithm of sweet potency (log SP) relative to sucrose
132 CHEMBL848721 Alkaline hydrolysis rate of the compound
182 CHEMBL876466 Lipophilicity determined as logarithm of the partition coefficient in the alkane/water system
107 CHEMBL875189 Binding affinity towards human Coagulation factor X
123 CHEMBL838701 Binding affinity for human adenosine A3 receptor
122 CHEMBL841787 Binding affinity against membrane transport protein PEPT1 in human Caco-2 cells
101 CHEMBL829005 Inhibition of [3H]Ro-151788 binding to recombinant human gamma-aminobutyric acid A receptor alpha-2-beta-3-gamma-2 subtype expressed in L (tk-) cells
101 CHEMBL829006 Inhibition of [3H]Ro-151788 binding to recombinant human gamma-aminobutyric-acid A receptor alpha-1-beta-3-gamma-2 subtype expressed in L (tk-) cells
101 CHEMBL830420 Inhibition of [3H]Ro-151788 binding to recombinant human gamma-aminobutyric-acid A receptor alpha-3-beta-3-gamma-2 subtype expressed in L (tk-) cells
101 CHEMBL830421 Inhibition of [3H]Ro-151788 binding to recombinant human gamma-aminobutyric-acid A receptor alpha-5-beta-3-gamma-2 subtype expressed in L (tk-) cells
177 CHEMBL830957 Inhibition of rat liver dihydrofolate reductase
177 CHEMBL828662 Inhibition of Toxoplasma gondii dihydrofolate reductase
177 CHEMBL829401 Inhibition of Pneumocystis carinii dihydrofolate reductase
108 CHEMBL829091 Inhibitory concentration against human ER beta expressed in Escherichia coli was determined using [3H]17-beta-estradiol as radio ligand
107 CHEMBL829540 Inhibitory concentration against human ER alpha expressed in Escherichia coli was determined using [3H]17-beta-estradiol as radio ligand
103 CHEMBL828644 Concentration required for complete inhibition of Nuclear factor kappa B DNA binding
177 CHEMBL830838 Inhibition of rat liver dihydrofolate reductase
177 CHEMBL830839 Inhibition of Toxoplasma gondii dihydrofolate reductase
177 CHEMBL830842 Inhibition of Pneumocystis carinii dihydrofolate reductase
124 CHEMBL831723 Selectivity fold for estrogen receptor beta over estrogen receptor alpha
106 CHEMBL833931 Inhibitory activity against wild type HIV-1 LAI cell line
106 CHEMBL840794 Selectivity index of cytotoxic activity (CC50) to inhibitory activity (IC50) relative to LAI cell line
119 CHEMBL872182 Inhibitory concentration against recombinant rat androgen receptor expressed in Escherichia coli using [3H]methyltrienolone (R 1881)
133 CHEMBL864467 Inhibitory activity against dynamin1 GTPase expressed in sheep brain
162 CHEMBL858719 Inhibitory activity against DNA-dependent protein kinase receptor
163 CHEMBL862098 Binding affinity to recombinant human adenosine A2B receptor
149 CHEMBL862097 Binding affinity to recombinant human adenosine A2A receptor
139 CHEMBL862099 Selectivity for human adenosine A2B over human adenosine A2A receptor
206 CHEMBL862100 Displacement of [3H]DPCPX from recombinant human adenosine A2B receptor expressed in HEK293 cells at 0.1 uM
184 CHEMBL862101 Displacement of [3H]DPCPX from recombinant human adenosine A2B receptor expressed in HeLa cells at 0.01 uM
206 CHEMBL853017 Displacement of [3H]ZM-241385 from recombinant human adenosine A2A receptor expressed in HEK293 cells at 0.1 uM
113 CHEMBL867029 Inhibitory activity against HCV delta 21 NS5B RNA polymerase by SPA assay
101 CHEMBL859942 Antifungal activity against Candida albicans
113 CHEMBL861583 Inhibition of NF-kappaB DNA binding by EMSA
124 CHEMBL861584 Activity against human urotensin-2 receptor expressed in NIH3T3 cells
110 CHEMBL852974 Inhibition of MetAP2
109 CHEMBL852975 Inhibition of MetAP2 in presence of 40 mg/ml human serum albumin
109 CHEMBL852976 Antiproliferative activity against HT1080
109 CHEMBL852977 Antiproliferative activity against HT1080 in presence of 40 mg/ml human serum albumin
103 CHEMBL864855 Inhibition of human Wee1 in presence of 9.5 uM ATP
103 CHEMBL864856 Inhibition at human Chk1 in presence of 4 uM ATP
106 CHEMBL863649 Activity at human recombinant D4.4 receptor expressed in HEK293 cells by FLIPR assay
106 CHEMBL863650 Activity at human recombinant D4.4 receptor expressed in HEK293 cells by FLIPR assay relative to dopamine
106 CHEMBL866786 Agonist activity at human recombinant D2 receptor expressed in HEK293 cells by FLIPR assay
106 CHEMBL866136 Antagonist activity at human recombinant D2 receptor expressed in HEK293 cells by FLIPR assay
157 CHEMBL908895 Ability to open human urinary bladder Kir6.2 channel containing SUR2B in Ltk cells by FLIPR assay
129 CHEMBL908896 Ability to open human urinary bladder Kir6.2 containing SUR2B in Ltk cells by FLIPR assay relative to P1075
149 CHEMBL913512 Displacement of [125I]CCK-8S from human CCK1R
117 CHEMBL910461 Antibacterial activity against Escherichia coli W3110
133 CHEMBL914372 Inhibition of rat recombinant FAAH expressed in Escherichia coli by [14C]oleamide breakdown
155 CHEMBL915807 Inhibition of Plasmodium falciparum FcB1 M1 aminopeptidase at 10 uM
155 CHEMBL915809 Inhibition of pig kidney microsomal APN at 10 uM
258 CHEMBL918058 Cytotoxicity against mouse L1210/0 cells after 48 hrs
159 CHEMBL914418 Inhibition of P-glycoprotein expressed in MDR CCRF vcr1000 cells by daunorubicin efflux assay
111 CHEMBL916755 Inhibition of DNA-PK in HeLa cell nuclear extracts
123 CHEMBL920042 Displacement of [3H]DPCPX from human adenosine A1 receptor expressed in CHO cells
111 CHEMBL888481 Inhibition of rat recombinant FAAH expressed in Escherichia coli
120 CHEMBL890276 Displacement of [3H]cytisine from alpha-4-beta-2 in rat cerebral cortical membrane
164 CHEMBL894050 Inhibition of ENT1 in human K562 cells by flow cytometric assay
251 CHEMBL896240 Inhibition of Plasmodium falciparum protein farnesyltransferase at 50 nM by scintillation proximity assay
253 CHEMBL896241 Inhibition of Plasmodium falciparum protein farnesyltransferase at 5 nM by scintillation proximity assay
239 CHEMBL896242 Inhibition of Plasmodium falciparum protein farnesyltransferase at 0.5 nM by scintillation proximity assay
258 CHEMBL896244 Antimalarial activity against Plasmodium falciparum 3D7
235 CHEMBL896245 Antimalarial activity against Plasmodium falciparum K1
215 CHEMBL895371 Inhibition of human Pgp-mediated DNR transport in NIH3T3 cells by microplate assay
114 CHEMBL899883 Displacement of [3H]cytisine from neuronal nicotinic acetylcholine receptor in rat brain membrane
110 CHEMBL899886 Agonist activity at recombinant human alpha-4-beta-2 nAChR expressed in HEK293 cells assessed as induction of calcium influx by FLIPR assay
102 CHEMBL899884 Agonist activity at recombinant human alpha-3-beta-4 nAChR expressed in HEK293 cells assessed as induction of calcium influx by FLIPR assay
103 CHEMBL900188 Inhibition of transthyretin fibril formation at pH 4.4 at 100 uM
216 CHEMBL899098 Inhibition of rat human chimera TRPV1 channel expressed in CHO cells
114 CHEMBL944092 Activation of SMN2 promoter in mouse NSC34 cells assessed as induction of beta-lactamase activity
118 CHEMBL949088 Inhibition of rat recombinant FAAH expressed in Escherichia coli
151 CHEMBL930273 Inhibition of recombinant GSK3-beta
128 CHEMBL952131 Inhibition of EGFR
108 CHEMBL931641 Displacement of [3H]CP-55940 from human recombinant CB2 receptor expressed in HEK cells
108 CHEMBL931642 Displacement of [3H]CP-55940 from human recombinant CB1 receptor expressed in HEK cells
181 CHEMBL944276 Inhibition of human recombinant EGFR
123 CHEMBL938648 Inhibition of FAAH
356 CHEMBL1002252 Cytotoxicity against human DU145 cells after 48 hrs by SRB assay
240 CHEMBL1002253 Cytotoxicity against human LNcaP cells after 48 hrs by SRB assay
339 CHEMBL1004797 Cytotoxicity against human IGROV cells after 48 hrs by SRB assay
339 CHEMBL1004798 Cytotoxicity against human IGROV-ET cells after 48 hrs by SRB assay
261 CHEMBL1004799 Cytotoxicity against human SKBR3 cells after 48 hrs by SRB assay
356 CHEMBL1004800 Cytotoxicity against human SK-MEL-28 cells after 48 hrs by SRB assay
363 CHEMBL1004801 Cytotoxicity against human A549 cells after 48 hrs by SRB assay
321 CHEMBL1004802 Cytotoxicity against human K562 cells after 48 hrs by SRB assay
339 CHEMBL1004803 Cytotoxicity against human PANC1 cells after 48 hrs by SRB assay
365 CHEMBL1004804 Cytotoxicity against human HT29 cells after 48 hrs by SRB assay
339 CHEMBL1004805 Cytotoxicity against human LoVo cells after 48 hrs by SRB assay
284 CHEMBL1004806 Cytotoxicity against human doxorubicin resistant LoVo cells after 48 hrs by SRB assay
321 CHEMBL1004807 Cytotoxicity against human HeLa cells after 48 hrs by SRB assay
321 CHEMBL1004808 Cytotoxicity against human HeLa-APL cells after 48 hrs by SRB assay
231 CHEMBL979906 Displacement of [3H]PDBu form mouse PKCalpha by scintillation counting
212 CHEMBL1031359 Inhibition of HIV1 protease Q7K mutant by FRET method
185 CHEMBL993349 Inhibition of 4-(4-(dimethylamino)styryl)-N-methylpyridinium uptake at human OCT1 expressed in HEK293 cells at 100 uM by confocal microscopy
130 CHEMBL1024870 Inhibition of HSL in Wistar rat isolated fat cells by spectrophotometric assay
118 CHEMBL1028089 Inhibition of human recombinant geranylgeranyl diphosphate synthase
108 CHEMBL1028192 Binding affinity to ERalpha assessed as inhibition of fluorescein-labeled nuclear receptor domain of steroid receptor coactivator 3 by TR-FRET assay
108 CHEMBL1028193 Binding affinity to ERbeta assessed as inhibition of fluorescein-labeled nuclear receptor domain of steroid receptor coactivator 3 by TR-FRET assay
140 CHEMBL1027667 Inhibition of human ERG channel
189 CHEMBL1006005 Effect on human MRP2-mediated estradiol-17-beta-glucuronide transport in Sf9 cells inverted membrane vesicles relative to control
101 CHEMBL961424 Activation of human estrogen receptor alpha expressed in HEK293 cells at 10 uM by beta-galactosidase reporter gene assay relative to 3,17 beta-estradiol
101 CHEMBL966124 Activation of human estrogen receptor beta expressed in HEK293 cells at 10 uM beta-galactosidase reporter gene assay relative to 3,17-beta-estradiol
113 CHEMBL962075 Antifungal activity against Candida parapsilosis ATCC 22019 at 35 degC after 48 hrs by broth microdilution test
171 CHEMBL962076 Antifungal activity against Candida albicans ATCC 10261 at 35 degC after 48 hrs by broth microdilution test
167 CHEMBL962077 Antifungal activity against Candida albicans ATCC 10261 at 35 degC after 48 to 96 hrs by broth microdilution test
391 CHEMBL965578 Inhibition of mouse brain MAOA
244 CHEMBL965580 Inhibition of mouse brain MAOB
171 CHEMBL1021377 Inhibition of purified human recombinant APE1 expressed in Escherichia coli M15 cells
200 CHEMBL1017996 Antimicrobial activity against Pseudomonas aeruginosa H1001 expressing luciferase gene assessed as ratio antimicrobial IC50 for drug to Bac2A peptide by luminescence assay
109 CHEMBL1026933 Inhibition of PTP1B
119 CHEMBL1026934 Inhibition of Chk1
390 CHEMBL1035433 Total body clearance in human
390 CHEMBL1035434 Renal clearance in human
111 CHEMBL1034532 Therapeutic index, ratio of EC50 for human HepG2 cells to IC50 for human TRbeta receptor
147 CHEMBL1034533 Inhibition of SRC2 binding to human TRbeta receptor ligand binding domain expressed in Escherichia coli BL21 (DE3) by fluorescence polarization assay
147 CHEMBL1034534 Cytotoxicity against human HepG2 cells after 48 hrs by luminescence cell viability assay
147 CHEMBL1034535 Aqueous solubility in phosphate buffered saline by multi-screen solubility assay
131 CHEMBL1034536 Permeability at pH 7.4 by PAMPA method
111 CHEMBL1034538 Inhibition of human ERG expressed in HEK293 cells assessed as blockade of KCl-stimulated depolarization relative to terfenadine
101 CHEMBL1056887 Antiviral activity against HIV-1 LAI harboring wild type reverse transcriptase infected in human MT4 cells after 5 days by MTT assay
101 CHEMBL1056889 Antiviral activity against HIV1 HXB2 harboring K103N mutant reverse transcriptase infected in human MT4 cells after 5 days by MTT assay
101 CHEMBL1056890 Antiviral activity against HIV1 HXB2 harboring Y181C mutant reverse transcriptase infected in human MT4 cells after 5 days by MTT assay
101 CHEMBL1056891 Antiviral activity against HIV1 HXB2 harboring Y188L mutant reverse transcriptase infected in human MT4 cells after 5 days by MTT assay
108 CHEMBL1041515 Growth inhibition of VHL-null human RCC4 cells after 4 days by XTT assay
108 CHEMBL1041516 Ratio of IC50 for human RCC4-VHL cells to IC50 for VHL-null human RCC4 cells
276 CHEMBL1043580 Fraction unbound in human plasma
308 CHEMBL1043581 Total clearance in human
308 CHEMBL1043582 Hepatic clearance in human
308 CHEMBL1043583 Renal clearance in human
308 CHEMBL1043584 Oral bioavailability in human
308 CHEMBL1043585 Fraction absorbed in human
308 CHEMBL1043586 Fraction escaping gut-wall elimination in human
308 CHEMBL1043587 Fraction escaping hepatic elimination in human
300 CHEMBL1043588 Volume of distribution at steady state in human
138 CHEMBL1040875 Displacement of [3H]CP-55940 from human recombinant CB2 receptor expressed in HEK293 cells
138 CHEMBL1040876 Displacement of [3H]CP-55940 from human recombinant CB1 receptor expressed in CHO cells
116 CHEMBL1049617 Antitubercular activity against Mycobacterium tuberculosis H37Rv in aerobic condition after 7 days by microplate alamar blue assay
116 CHEMBL1049618 Antitubercular activity against Mycobacterium tuberculosis H37Rv in anaerobic condition after 7 days by low oxygen recovery assay
116 CHEMBL1049619 Cytotoxicity against african green monkey Vero cells after 72 hrs by MTS assay
258 CHEMBL1064897 Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
258 CHEMBL1064898 Antiplatelet aggregation activity against adenosine diphosphate-induced human platelet rich plasma assessed as inhibition of platelet aggregation by turbidimetric method
179 CHEMBL1064899 Relative potency, ratio of IC50 for drug to IC50 for AZD-6140 for platelet aggregation in human platelet rich plasma
175 CHEMBL1106724 Inhibition of human 17beta-HSD7 expressed in HEK293 cells assessed as inhibition of reduction of [14C]estrone into [14C]estradiol at 0.3 uM after 7 hrs
124 CHEMBL1106725 Inhibition of human 17beta-HSD7 expressed in HEK293 cells assessed as inhibition of reduction of [14C]estrone into [14C]estradiol at 3 uM after 7 hrs
128 CHEMBL1114854 Agonist activity at human PPARalpha ligand binding domain expressed in human 293T cells co-transfected with Gal4-DBD by luciferase transactivation assay
128 CHEMBL1114855 Agonist activity at human PPARgamma ligand binding domain expressed in human 293T cells co-transfected with Gal4-DBD by luciferase transactivation assay
136 CHEMBL1114856 Agonist activity at human PPARdelta ligand binding domain expressed in human 293T cells co-transfected with Gal4-DBD by luciferase transactivation assay
116 CHEMBL1115672 Agonist activity at human PPARdelta ligand binding domain expressed in human 293T cells co-transfected with Gal4-DBD by luciferase transactivation assay relative to GW-501516
105 CHEMBL1107667 Antagonist activity at human Dopamine D3 receptor expressed in CHO cell by GTPgammaS binding assay
105 CHEMBL1107668 Antagonist activity at human Dopamine D2 receptor expressed in CHO cell by GTPgammaS binding assay
104 CHEMBL1107669 Binding affinity to human histamine H3 receptor expressed in CHO cells by FLIPR assay
105 CHEMBL1107671 Displacement of [3H]dofetidile from human ERG by scintillation proximity assay
423 CHEMBL1100169 Inhibition of rat recombinant Rab geranylgeranyltransferase at 100 uM in presence of canine Rab7 and rat REP1 NBD-FPP based continuous fluorimetric assay
103 CHEMBL1115235 Inhibition of human recombinant C-terminal FLAG-tagged autotaxin expressed in baculovirus-infected Sf9 cells assessed as FS-3 hydrolysis at 10 uM relative to control
124 CHEMBL1114505 Antimicrobial activity against Escherichia coli
107 CHEMBL1114507 Antimicrobial activity against Pseudomonas aeruginosa
152 CHEMBL1119315 Inhibition of Plasmodium falciparum falcipain-2 after 12 hrs by fluorescence spectroscopy-based on-bead assay
155 CHEMBL1119323 Inhibition of Trypanosoma brucei rhodesiense rhodesain after 12 hrs by fluorescence spectroscopy-based on-bead assay
249 CHEMBL1166701 Growth inhibition of human NCI60 cells after 48 hrs by SRB assay
204 CHEMBL1219695 Inhibition of Plasmodium falciparum falcipain-2 expressed in Escherichia coli
204 CHEMBL1219696 Inhibition of Plasmodium falciparum falcipain-3 expressed in Escherichia coli
108 CHEMBL1246346 Antiparasitic activity against Toxoplasma gondii infected in HFF after 24 hrs by [3H]uracil incorporation assay
106 CHEMBL1249049 Inhibition of human AChE by Ellmans test
128 CHEMBL1273257 Inhibition of factor 10a
114 CHEMBL1634494 Solubility of the compound in water at pH 7.0 by HPLC
121 CHEMBL1634496 Antitubercular activity against Mycobacterium tuberculosis H37Rv by MABA method
121 CHEMBL1634497 Antitubercular activity against Mycobacterium tuberculosis H37Rv by LORA method
112 CHEMBL1657423 Inhibition of NorA in Staphylococcus aureus 1199B assessed as reduction in ethidium bromide efflux at 50 uM by fluorimetry after 5 mins
124 CHEMBL1663615 Antibiofilm activity in Salmonella Typhimurium ATCC 14028 assessed as inhibition of biofilm formation at 25 degC after 24 hrs
113 CHEMBL1663702 Antibiofilm activity in Pseudomonas aeruginosa assessed as inhibition of biofilm formation at 25 degC after 24 hrs
124 CHEMBL1678466 Activity at recombinant Gcase N370S mutant in human spleen homogenates assessed as half maximal activity concentration of hydrolysis of 4-MU-beta-D-glucose
149 CHEMBL1678649 Inhibition of alpha-glucosidase
149 CHEMBL1678650 Inhibition of alpha-galactosidase
110 CHEMBL1804799 Permeability of the compound by PAMPA method at pH 7.4
124 CHEMBL1798236 Antiproliferative activity against human SKBR3 cells expressing HER2 after 72 hrs by MTS/PMS assay
117 CHEMBL1798237 Antiproliferative activity against human MCF7 cells expressing estrogen receptor after 72 hrs by MTS/PMS assay
117 CHEMBL1798238 Antiproliferative activity against human androgen-dependent LNCaP-LN3 cells after 72 hrs by MTS/PMS assay
117 CHEMBL1798239 Antiproliferative activity against human androgen-independent PC3MM2 cells after 72 hrs by MTS/PMS assay
110 CHEMBL1804800 Partition coefficient, log D of the compound at pH 7.4 by HPLC analysis
115 CHEMBL1804794 Antimalarial activity against chloroquine and pyrimethamine-resistant Plasmodium falciparum W2 infected in human A positive erythrocytes after 72 hrs by SYBR Green I assay
114 CHEMBL1804795 Antimalarial activity against chloroquine, mefloquine, pyrimethamine and atovaquone-resistant Plasmodium falciparum TM90-C2B infected in human A positive erythrocytes after 72 hrs by SYBR Green I assay
111 CHEMBL1804796 Resistance index, ratio of EC50 for chloroquine, mefloquine, pyrimethamine and atovaquone-resistant Plasmodium falciparum TM90-C2B to EC50 for chloroquine and pyrimethamine-resistant Plasmodium falciparum W2
109 CHEMBL1804797 Cytotoxicity against mouse J774 cells after 72 hrs by Cell titer 96 aqueous one solution cell proliferation assay
110 CHEMBL1804798 Aqueous solubility of compound at pH 7.4 by HPLC analysis
112 CHEMBL1804802 Cytotoxicity index, ratio of EC50 for mouse J774 cells to EC50 for chloroquine, mefloquine, pyrimethamine and atovaquone-resistant Plasmodium falciparum TM90-C2B
138 CHEMBL1819839 Agonist activity at recombinant human vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assay
138 CHEMBL1819840 Agonist activity at recombinant human vasopressin V1b receptor expressed in Flp-In-293 cells by luciferase reporter gene assay
138 CHEMBL1819841 Agonist activity at recombinant human vasopressin V2 receptor expressed in HEK293 cells by luciferase reporter gene assay
138 CHEMBL1819842 Agonist activity at human OT receptor expressed in CHO-K1 cells by luciferase reporter gene assay
133 CHEMBL1826381 Activation of SMN expressed in HEK293 cells assessed as concentration required to reach 50% of maximum luciferase signal by SMN2-promotor driven luciferase reporter gene assay
112 CHEMBL1827733 Displacement of [3H]ketanserin from human recombinant serotonin 5-HT2A receptor expressed in CHO-K1 cells
112 CHEMBL1827734 Displacement of [3H]mesulergine from human recombinant 5-HT2C receptor expressed in CHO-K1 cells
112 CHEMBL1827735 Displacement of [3H]impiramine from human serotonin transporter membrane expressed in HEK293 cells
113 CHEMBL1839642 Antituberculosis activity against Mycobacterium tuberculosis H37Rv under aerobic conditions by microplate alamar blue assay
113 CHEMBL1839643 Antituberculosis activity against Mycobacterium tuberculosis H37Rv under anaerobic conditions by fluorescence based low-oxygen-recovery assay
112 CHEMBL1837544 Solubility of the compound at pH 7.4 after 18 hrs by UV spectroscopic analysis
112 CHEMBL1837545 Permeability of the compound at pH 7.4 after 30 mins by PAMPA
112 CHEMBL1837546 Dissociation constant, pKa of the compound
113 CHEMBL1837547 Antimalarial activity against chloroquine-sensitive Plasmodium falciparum 3D7 infected in human erythrocytes assessed as reduction in parasitemia after 72 hrs by spectrophotometry
113 CHEMBL1837548 Antimalarial activity against chloroquine-resistant Plasmodium falciparum K1 infected in human erythrocytes assessed as reduction in parasitemia after 72 hrs by spectrophotometry
113 CHEMBL1837682 Ratio of EC50 for chloroquine-resistant Plasmodium falciparum K1 infected in human erythrocytes to EC50 for chloroquine-sensitive Plasmodium falciparum 3D7 infected in human erythrocytes
113 CHEMBL1837683 Cytotoxicity against human HepG2 cells assessed as intracellular ATP level after 72 hrs by Celltiter-Glo luminescent assay
113 CHEMBL1837684 Ratio of EC50 for human HepG2 cells to EC50 for Plasmodium falciparum 3D7 infected in human erythrocytes
113 CHEMBL1837685 Ratio of EC50 for human HepG2 cells to EC50 for Plasmodium falciparum K1 infected in human erythrocytes
118 CHEMBL1920461 Cytotoxicity against human PC3 cells
118 CHEMBL1920462 Cytotoxicity against human HeLa cells
116 CHEMBL1920463 Antimicrobial activity against Micrococcus luteus ATCC 10240 after 24 hrs by Kirby-Bauer agar diffusion assay
118 CHEMBL1920731 Cytotoxicity against human MCF7 cells
122 CHEMBL1920639 Displacement of [3H]PGD2 from human CRTH2 expressed in chinese hamster CHO cells by liquid scintillation counting
173 CHEMBL1918735 Cytotoxicity against human HEK293 cells after 72 hrs by luminescence assay
173 CHEMBL1918736 Cytotoxicity against human Raji cells after 72 hrs by luminescence assay
173 CHEMBL1918737 Cytotoxicity against human HepG2 cells after 72 hrs by luminescence assay
173 CHEMBL1918738 Cytotoxicity against human BJ cells after 72 hrs by luminescence assay
173 CHEMBL1918739 Selectivity ratio of EC50 for human HepG2 cells to EC50 for Plasmodium falciparum
163 CHEMBL1960748 Inhibition of Dengue virus NS2B-NS3 protease using Abz-NleKRRS-3-(NO2)Y as substrate at 50 uM preincubated for 15 mins measured every sec for 15 mins by fluorimetric analysis
163 CHEMBL1960749 Inhibition of bovine plasma thrombin using Boc-Val-Pro-Arg-AMC as substrate at 25 uM preincubated for 15 mins measured after 10 mins by fluorimetric assay
163 CHEMBL1960750 Inhibition of Escherichia coli MurA using PEP as substrate assessed as inorganic phosphate release at 25 uM preincubated for 10 mins measured after 60 mins by fluorimetric assay
163 CHEMBL1960751 Inhibition of Escherichia coli MetAP at 10 uM after 15 mins by fluorescence analysis
110 CHEMBL2046255 Inhibition of recombinant AKR1C3 assessed as NADP+ dependent oxidation of S-tetralol by fluorescence assay
110 CHEMBL2046256 Inhibition of recombinant AKR1C2 assessed as NADP+ dependent oxidation of S-tetralol by fluorescence assay
109 CHEMBL2046257 Selectivity ratio of IC50 for recombinant AKR1C2 to IC50 for recombinant AKR1C3
106 CHEMBL2091156 Inhibition of human recombinant TG2 by fluorescent transamidation assay
140 CHEMBL2156781 Antiviral activity against Hepatitis C virus subtype 1b Con1 infected in human Huh7 cells assessed as inhibition of HCV replicon-encoded Renilla luciferase reporter activity after 72 hrs by HCV replicon assay
127 CHEMBL2155446 Inhibition of gamma secretase assessed as reduction in Abeta42 production
223 CHEMBL2169429 Inhibition of human liver OATP1B1 expressed in HEK293 Flp-In cells assessed as reduction in E17-betaG uptake at 20 uM by scintillation counting
223 CHEMBL2169430 Inhibition of human liver OATP1B3 expressed in HEK293 Flp-In cells assessed as reduction in [3H]E17-betaG uptake at 20 uM incubated for 5 mins by scintillation counting
223 CHEMBL2169431 Inhibition of human liver OATP2B1 expressed in HEK293 Flp-In cells assessed as reduction in [3H]E3S uptake at 20 uM incubated for 5 mins by scintillation counting
224 CHEMBL2186105 Antiviral activity against HCV genotype 1b infected to human HuH cells assessed as inhibition of RNA replication after 4 days by FRET assay
128 CHEMBL2213160 Modulation of gamma secretase in CHO-2B7 cells assessed as reduction in amyloid beta 42 level after 5 hrs by MSD ELISA
112 CHEMBL2317274 Inhibition of human recombinant His-GST tagged VCP expressed in baculovirus infected Hi5 cells assessed as ADP formation incubated for 20 mins proir to substrate addition measured after 90 mins by NADH coupled assay
113 CHEMBL2330505 Activation of human RXRalpha activity expressed in COS1 cells assessed as induction ratio at 50 uM after 12 hrs by RXRE-luciferase reporter gene assay relative to untreated control
104 CHEMBL2400521 Cytotoxicity against human K562 cells after 96 hrs by trypan blue exclusion assay
104 CHEMBL2400522 Cytotoxicity against human DU145 cells after 96 hrs by trypan blue exclusion assay
107 CHEMBL2400428 Activity at rat recombinant GluN1/GluN2D receptor expressed in Xenopus oocytes assessed as potentiation of glycine/glutamate-induced activation at 10 uM by two-electrode voltage clamp technique relative to control
107 CHEMBL2400429 Activity at rat recombinant GluN1/GluN2C receptor expressed in Xenopus oocytes assessed as potentiation of glycine/glutamate-induced activation at 10 uM by two-electrode voltage clamp technique relative to control
107 CHEMBL2400430 Activity at rat recombinant GluN1/GluN2B receptor expressed in Xenopus oocytes assessesed as potentiation of glycine/glutamate-induced effect at 10 uM by two-electrode voltage clamp technique
107 CHEMBL2400431 Activity at rat recombinant GluN1/GluN2A receptor expressed in Xenopus oocytes assessesed as potentiation of glycine/glutamate-induced effect at 10 uM by two-electrode voltage clamp technique
155 CHEMBL2423658 Inhibition of TDP2 (unknown origin) using 4-nitrophenyl phenylphosphonate as substrate after 60 mins
105 CHEMBL2433916 Positive allosteric modulation of rat mGluR5 stably expressed in HEK293 cells assessed as increase in intracellular calcium level by Fluo-4AM dye-based fluorescence assay
101 CHEMBL2443631 Inhibition of RyR2 R4496C mutant (unknown origin)-mediated store-overload induced calcium release expressed in HEK293 cells after 8 to 10 mins by fura-2/AM dye-based fluorescence assay
111 CHEMBL3089558 Cytotoxicity against human HL60 cells assessed as growth inhibition after 72 hrs by MTT assay
110 CHEMBL3111191 Inhibition of TLR9 in BALB/c mouse BMDM assessed as downregulation of CpG-stimulated IL-6 level at 5 ug/ml preincubated for 18 hrs followed by CpG challenge measured after 24 hrs by ELISA relative to control
110 CHEMBL3111192 Inhibition of TLR9 in BALB/c mouse BMDM assessed as downregulation of CpG-stimulated IL-12p40 level at 5 ug/ml preincubated for 18 hrs followed by CpG challenge measured after 24 hrs by ELISA relative to control
110 CHEMBL3111194 Inhibition of TLR2/6 in BALB/c mouse BMDM assessed as downregulation of BLP-stimulated IL-6 level at 5 ug/ml preincubated for 18 hrs followed by BLP challenge measured after 24 hrs by ELISA relative to control
110 CHEMBL3111195 Inhibition of TLR2/6 in BALB/c mouse BMDM assessed as downregulation of BLP-stimulated IL-12p40 level at 5 ug/ml preincubated for 18 hrs followed by BLP challenge measured after 24 hrs by ELISA relative to control
110 CHEMBL3111197 Inhibition of TLR4 in BALB/c mouse BMDM assessed as downregulation of LPS-stimulated IL-6 level at 5 ug/ml preincubated for 18 hrs followed by LPS challenge measured after 24 hrs by ELISA relative to control
110 CHEMBL3111198 Inhibition of TLR4 in BALB/c mouse BMDM assessed as downregulation of LPS-stimulated IL-12p40 level at 5 ug/ml preincubated for 18 hrs followed by LPS challenge measured after 24 hrs by ELISA relative to control
114 CHEMBL3122259 Antiviral activity against Hepatitis C virus infected in human HuH7 cells assessed as inhibition of HCV subgenomic replicon replication after 72 hrs by ELISA
126 CHEMBL3122260 Inhibition of Hepatitis C virus full-length NS3/4A protease assessed as quenched-fluorogenic RET-S1 substrate cleavage incubated for 10 mins prior to substrate addition by FRET analysis
245 CHEMBL3232194 Antitumor activity against mouse L1210 cells transfected in ip dosed C3H X DBA2 F1 hybrid mouse on day 0 and dosed at LD10 level once daily on days 1 to 5 assessed as increase in life span relative to control
127 CHEMBL3232195 Displacement of ethidium from calf thymus DNA by fluorimetric method
245 CHEMBL3232196 Toxicity in ip dosed C3H X DBA2 F1 hybrid mouse transfected with mouse L1210 cells on day 0 and dosed once daily on days 1 to 5 measured after 50 days
193 CHEMBL3232197 Antitumor activity against mouse L1210 cells transfected in ip dosed C3H X DBA2 F1 hybrid mouse on day 0 and dosed once daily on days 1 to 5 assessed as increase in life span relative to control
245 CHEMBL3232198 Lipophilic-hydrophilic balance, Rm of the compound by partition chromatography
127 CHEMBL3232200 Displacement of ethidium from poly[d(A-T)]-poly[d(A-T)] DNA by fluorimetric method
127 CHEMBL3232201 Displacement of ethidium from poly[d(G-C)]-poly[d(G-C)] DNA (unknown origin) by fluorimetric method
131 CHEMBL3232252 Lipophilicity, log P of the compound in 0.1 N HCl solution
630 CHEMBL3232253 Antimalarial activity against Plasmodium berghei
135 CHEMBL3240837 Inhibition of NorA in fluoroquinolone-resistant Staphylococcus aureus 1199B assessed as potentiation of 4 ug/ml of ciprofloxacin MIC at 100 ug/ml after 24 hrs by microdilution method
129 CHEMBL3240840 Toxicity in Staphylococcus aureus ATCC 25923 after 24 hrs by microdilution method
166 CHEMBL3252233 Analgesic activity in Sprague-Dawley rat brewer's yeast treated foot assessed as response threshold at 32 mg/kg, po
181 CHEMBL3252237 Analgesic activity in Sprague-Dawley rat normal foot assessed as response threshold at 32 mg/kg, po
101 CHEMBL3255097 Antitumor activity against mouse L1210 cells allografted in mouse assessed as increase of host lifespan
128 CHEMBL3253878 Antitumor activity against mouse L1210 cells allografted in mouse assessed as dose required to increase 40% of life span
106 CHEMBL3255367 Antitumor activity against mouse L1210 cells allografted in C3H/DBA2F1 hybrid mouse assessed as maximum increase of host life span administered as ip for 5 days relative to control
111 CHEMBL3266258 Antimicrobial activity against Candida albicans SC5314 after 24 hrs by serial dilution method
111 CHEMBL3266259 Antimicrobial activity against Candida albicans Y0109 after 24 hrs by serial dilution method
111 CHEMBL3266260 Antimicrobial activity against Candida parapsilosis 22019 after 24 hrs by serial dilution method
111 CHEMBL3266261 Antimicrobial activity against Cryptococcus neoformans 32609 after 72 hrs by serial dilution method
111 CHEMBL3266262 Antimicrobial activity against Candida glabrata 537 after 24 hrs by serial dilution method
111 CHEMBL3266263 Antimicrobial activity against Aspergillus fumigatus 7544 after 48 hrs by serial dilution method
105 CHEMBL3270181 Cytotoxicity against human HepG2 cells assessed as decrease in ATP signal after 2 days by CellTiter-Glo assay
104 CHEMBL3280748 Inhibition of liver dihydrofolate reductase (unknown origin)
111 CHEMBL3284063 Binding affinity to chymotrypsin (unknown origin)
121 CHEMBL3283306 Toxicity in po dosed mouse assessed as mortality after 7 days
121 CHEMBL3283307 Hypotensive activity in po dosed spontaneously hypertensive Wistar-Okamoto rat assessed as dose required to cause 30 mmHg fall of blood pressure administered for 5 days
126 CHEMBL3285081 In vivo antigoiter activity in rat
105 CHEMBL3370062 Positive allosteric modulator activity at human muscarinic acetylcholine receptor subtype 5 expressed in CHO cells by calcium mobilization assay
122 CHEMBL3414284 Antibacterial activity against methicillin-sensitive Staphylococcus aureus ATCC 29213 after 16 to 20 hrs by broth microdilution method
107 CHEMBL3419139 Inhibition of Vps75-stimulated recombinant Saccharomyces cerevisiae histone acetyltransferase Rtt109 using Asf1-dH3-H4 as substrate assessed as coenzyme A production after 45 mins by CPM based HTS assay
104 CHEMBL3419140 Inhibition of Vps75-stimulated recombinant Saccharomyces cerevisiae histone acetyltransferase Rtt109 using Asf1-dH3-H4 as substrate assessed as coenzyme A production after 45 mins by CoA-based HTS counter screen assay
104 CHEMBL3419141 Inhibition of Vps75-stimulated recombinant Saccharomyces cerevisiae histone acetyltransferase Rtt109 assessed as H3K56 acetylated product at 125 uM after 45 mins by Slot bolt inhibiton assay
104 CHEMBL3419142 Inhibition of Vps75-stimulated recombinant Saccharomyces cerevisiae histone acetyltransferase Rtt109 assessed as H3K27 acetylated product at 125 uM after 45 mins by Slot bolt inhibiton assay
104 CHEMBL3419143 Fluorescence quenching assessed as fluorescence signal reduction at 10 uM after 10 mins
104 CHEMBL3419144 Fluorescence quenching in HTS buffer assessed as fluorescence signal reduction at 10 uM after 10 mins
104 CHEMBL3419553 Fluorescence quenching in HTS buffer with 7.5 uM CoA assessed as fluorescence signal reduction at 10 uM after 10 mins
104 CHEMBL3419578 Fluorescence quenching in HTS buffer with 20 uM 7-diethylamino-3-(4'-maleimidyl-phenyl)-4-methylcoumarin assessed as fluorescence signal reduction at 10 uM after 10 mins
